Pacific Biosciences Posts $140M Loss, $1.7M in Revenues for 2010

PacBio is preparing for the full commercial release of its real-time, single-molecule sequencing system and had a backlog of around $24 million as of the end of the year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories